glp-1 drug updates Pipeline Update: August 2025 - Prime Therapeutics January 2026: New or Expanded

Medica has denied me for this and is requiring a 3 month dietary restriction to be approved

At Perfect B in Doral, that evaluation replaces guesswork with monitored, evidence based options matched to your body rather than a marketplace product label

Importantly, this includes people who have both Medicaid and Medicare, known as dual eligibles

Another study, using dulaglutide, reported a medium-to-large effect size for reducing alcohol use in people with obesity, although no benefit was seen in heavy drinkers [35]

As demand for weight loss treatments like Semaglutide and Tirzepatide surged, retail pharmacies provided a reliable and familiar channel for prescription fulfillment

However, GLP-1 has a very short half-life of about 1.5 minutes and is rapidly suppressed by an enzyme called dipeptidyl peptidase-4 (DPP-4)